Introduction to Fotivda (Tivozanib) 1.34mg

Fotivda (Tivozanib) 1.34mg is a prescription medicine used in the treatment of advanced kidney cancer, particularly renal cell carcinoma (RCC). This medicine belongs to a specialized group of targeted cancer therapies that work by blocking signals that tumors use to grow new blood vessels.

Fotivda (Tivozanib) 1.34mg is classified under Prescription Medicines, Oncology Medicines, Anticancer Drugs, and Targeted Cancer Therapies. It contains Tivozanib, which works by inhibiting vascular endothelial growth factor receptors (VEGFR) that promote tumor blood supply.

In some markets, Tivoxen 1.34mg is available as a generic brand containing the same active ingredient Tivozanib, offering a similar therapeutic effect when prescribed by a qualified healthcare professional.

What Is Fotivda (Tivozanib) 1.34mg?

Fotivda is the original brand name for Tivozanib, an oral medication widely used for the treatment of advanced renal cell carcinoma.

Tivozanib belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs). These medicines work by targeting specific enzymes involved in tumor growth and blood vessel formation.

Generic versions such as Tivoxen 1.34mg contain the same active compound and may be used depending on physician recommendation and regional availability.

Drug Class and Mechanism of Action

Tivozanib is classified as a vascular endothelial growth factor receptor (VEGFR) inhibitor with strong anti-angiogenic and antineoplastic properties.

How Tivozanib Works

It works in several ways:

• Inhibits VEGF receptors involved in tumor blood vessel formation
• Prevents tumors from developing new blood vessels (anti-angiogenesis)
• Slows tumor growth by limiting oxygen and nutrient supply

Through these mechanisms, Tivozanib helps control the progression of advanced kidney cancer.

How Fotivda (Tivozanib) 1.34mg Works in the Body

Cancer cells often require new blood vessels to grow and spread. Fotivda targets the pathways responsible for forming these vessels.

Key Actions of Tivozanib

• Blocks VEGFR signaling pathways that stimulate angiogenesis
• Reduces tumor blood supply
• Helps slow tumor growth and disease progression

Some generic versions such as Tivoxen deliver the same active compound, allowing similar targeted cancer therapy when prescribed appropriately.

Medical Uses of Fotivda (Tivozanib) 1.34mg

Fotivda 1.34mg is widely prescribed for certain advanced cancers.

Fotivda for Renal Cell Carcinoma (RCC)

For patients with advanced renal cell carcinoma, Fotivda may be used as a targeted therapy to control tumor progression.

Potential Benefits

• Slows progression of kidney cancer
• Reduces tumor blood supply
• Helps extend progression-free survival in some patients

Generic alternatives like Tivoxen 1.34mg may also be used under medical supervision when Tivozanib therapy is recommended.

Who Can Take Tivoxen 1.34mg?

Because Tivozanib is a potent targeted therapy medicine, treatment should always be supervised by an experienced healthcare provider.

Eligibility Criteria

Patients may be prescribed Fotivda if they:

• Are diagnosed with advanced or metastatic renal cell carcinoma
• Require targeted anti-angiogenic cancer therapy
• Have been evaluated for blood pressure and cardiovascular risk factors

Certain generic options such as Tivoxen may also be considered depending on availability and physician decision.

Who Should Avoid Fotivda (Tivozanib) 1.34mg

Fotivda should NOT be used by:

• Individuals with hypersensitivity to Tivozanib
• Patients with uncontrolled high blood pressure
• Individuals with severe cardiovascular conditions unless monitored by a specialist

Fotivda (Tivozanib) 1.34mg Dosage and Administration

Standard Dosage Guidelines

Typical dosage recommendations include:

• Fotivda 1.34mg once daily
• Usually taken in 21-day treatment cycles followed by 7 days off
• Capsules should be swallowed whole with water
• Can be taken with or without food

Dosage Adjustments

Doctors may adjust the dose depending on:

• Blood pressure levels
• Liver function tests
• Individual treatment response or side effects

Side Effects of Fotivda 1.34mg

Like all cancer medicines, Fotivda may cause side effects.

Common Side Effects

• High blood pressure
• Fatigue or weakness
• Diarrhea
• Loss of appetite

Serious Side Effects

Severe Hypertension: Elevated blood pressure requiring medical management
Bleeding Risks: Increased risk of bleeding events
Heart Problems: Rare cardiovascular complications

Patients should report any unusual symptoms to their doctor immediately.

Storage:
Store below 25°C in a cool, dry place, protected from moisture and direct sunlight. Keep the capsules in their original packaging and out of reach of children.

Frequently Asked Questions (FAQs)

1. What is Fotivda (Tivozanib) 1.34mg used for?

Fotivda is used to treat advanced renal cell carcinoma by blocking tumor blood vessel formation and slowing cancer progression.

2. Is Tivozanib a chemotherapy drug?

No. Tivozanib is a targeted therapy known as a tyrosine kinase inhibitor that specifically blocks VEGF receptor signaling.

3. How is Fotivda usually taken?

It is typically taken once daily for 21 days followed by a 7-day break as part of a treatment cycle.

4. Can Fotivda increase blood pressure?

Yes. High blood pressure is a common side effect, so patients should have their blood pressure monitored regularly.

5. Is Tivoxen 1.34mg the same as Fotivda?

Tivoxen 1.34mg contains Tivozanib, the same active ingredient found in Fotivda. Generic versions is available. 

6. Do I need a prescription to buy Tivoxen (Tivozanib) 1.34mg?

Yes. Tivoxen 1.34mg is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.

Medical Disclaimer

Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Fotivda (Tivozanib) 1.34mg is a prescription-only medication and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.